San Diego County News

Independent publication serving San Diego County

  • Local
    • Central San Diego
    • North County
    • East County
    • South Bay
    • Northeastern
    • Temecula
  • Entertainment
    • Music
    • Television
    • Art
    • Theater
    • Film
    • Events
    • Theme Parks
    • Podcast/Radio
    • Museums
    • Books
  • Business
  • National
  • Politics
  • Sports
  • Health
    • Health Business
    • Health Education
    • Medical
  • Lifestyle
    • Travel
    • Food
    • Lifestyle
    • Senior Life
    • Society
  • Commentary
  • Home

FDA licenses new influenza vaccine designed for people 65 and older

December 29, 2009 By sdcnews

A patient receives influenza virus vaccine. Courtesy photo: Sanofi Pasteur

(PRNewswire)–Sanofi Pasteur, the vaccines division of the sanofi-aventis Group announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental biologics license application (sBLA) for licensure of Fluzone® High-Dose (Influenza Virus Vaccine). The new vaccine, for adults 65 years of age and older, will be available to health-care providers for immunizations administered this fall in preparation for the upcoming 2010-2011 influenza season.

“This new addition to Sanofi Pasteur’s vaccine portfolio reflects our long-standing commitment to public health and to research and development of new vaccines for enhanced prevention of influenza,” said Wayne Pisano, President and Chief Executive Officer of Sanofi Pasteur. “In 2011, the first baby boomers will turn 65 and, by the year 2030, the number of adults over age 65 is anticipated to double and surpass 70 million people, or 20 percent of the U.S. population. We are excited to introduce Fluzone High-Dose vaccine which will provide health-care professionals with a new vaccine to help prevent influenza in their patients over the age of 65.”

Trending
One man dead, one seriously injured in San Marcos shooting

Fluzone High-Dose vaccine was specifically designed to generate a more robust immune response in people 65 years of age and older. This age group typically does not respond as well to the standard dose of influenza virus vaccines as younger individuals because they have weakened immune systems.

 

40

SHARES
Share on Facebook
Tweet
Follow us

Comments

comments

Filed Under: Health, Medical


Support Independent Journalism



Environment

EPA proposes to strengthen air quality standards

January 7, 2023 By sdcnews

Science & Technology

Little rodent, big appetite

December 22, 2022 By sdcnews

Advertisement

Start planning your Travel Tuesday getaway! Just enter code TRAVELT35 for up to $35 off our fees on flights and be ready to take off.

Trending

School Sports

Animal News

Helen Woodward Animal Center meets UN Council

December 22, 2022 By sdcnews

Community Events

Things To Do

Categories

  • About Us
  • Archive
  • Contact Us
  • Private Policy
  • Terms of Service
  • Things To Do

Follow @SanCounty

Privacy Policy

Terms of service

Copyright © 2023 San Diego County News